Bullish
Spectral AI Announces Submission to FDA of its DeepView® System
DALLAS, June 30, 2025 ( GLOBE NEWSWIRE ) -- Spectral AI ( NASDAQ: MDAI ) ( "Spectral AI" or the "Company" ) , developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ( "FDA" ) in 2018 and uses multi-spectral imaging ...